Paul Rivard

Insider Reports History

Location
New York, NY
Signature
/s/ Paul Rivard
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Paul Rivard:

Company Role Class Num Shares Value Price $ Report Date Ownership
MyMD Pharmaceuticals, Inc. Chief Legal Officer Common stock 400,000 $444,000 $1.11 24 Aug 2023 Direct
MyMD Pharmaceuticals, Inc. Chief Legal Officer Employee Stock Option (Right to Buy) 150,000 07 Jun 2023 Direct

Insider Reports Filed by Paul Rivard

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TNFA MyMD Pharmaceuticals, Inc. 24 Aug 2023 1 +$166,500 4 Chief Legal Officer 24 Aug 2023, 18:58
TNFA MyMD Pharmaceuticals, Inc. 17 Aug 2023 1 +$28,080 4 Chief Legal Officer 18 Aug 2023, 17:21
TNFA MyMD Pharmaceuticals, Inc. 07 Jun 2023 1 $0 4 Chief Legal Officer 09 Jun 2023, 18:00
TNFA MyMD Pharmaceuticals, Inc. 08 Dec 2022 1 +$15,300 4 EVP of Operations, GC 08 Dec 2022, 19:24
TNFA MyMD Pharmaceuticals, Inc. 23 Nov 2021 1 +$90,450 4 EVP of Operations, GC 24 Nov 2021, 11:56
TNFA MyMD Pharmaceuticals, Inc. 14 Oct 2021 1 $0 4 EVP of Operations, GC 15 Oct 2021, 17:20